Office

Breakthrough Properties: Record funding, AI are powering the next era for life sciences

Life-changing discoveries are driving demand for research laboratories worldwide, say Breakthrough Properties’ Dan Belldegrun and Daniel D’Orazi.

Life sciences sees healthy competition from lenders

Continued demand for medical and life sciences space has investors partnering with private credit and alternative financing providers.

Core US life sciences markets receive clean bill of health

Demand is expected to return soon to the ‘big three’ – Boston, San Francisco and San Diego.

Pharmaceutical firms’ interest in AI brings shift in property requirements

Many R&D firms are moving from traditional lab spaces to premises that offer sufficient power and network capabilities.

JLL: Investment appetite for life sciences enters new phase

Equity investors and lenders increasingly look to the UK and continental European life sciences sector as the market continues to mature, say Chris Walters and Brad Greenway at JLL.

Understanding occupier trends vital for life sciences’ future

High supply means life sciences tenants can call the shots, so meeting evolving user needs is paramount for investors.

The future is bright for life sciences property

In 2024, market vacancies increased with new construction delivered vacant, but this trend should reverse as demand and supply return to more manageable levels.

Life sciences sees signs of recovery

Venture capital funding is rebounding, which is driving rental growth.

Investment appetite remains for life sciences real estate

Year-on-year sales volume for lab, R&D space has continued to fall, but a turnaround is expected.

Offices are coming out of exile

A spate of trophy deals in the last week signals institutions are warming up to the beleaguered asset class.